Research News
View articles by month and year
11–20 of 31 articles
-
Genetic Changes in DCIS Cells May Help Predict Invasive Breast Cancer Risk
New research suggests that certain genetic characteristics in DCIS cells may help predict the risk of future invasive breast cancer.
-
Genomic Test Results Not Understood by Many Women
A small study found that about a third of women who had genomic testing didn't really understand the test results.
-
Aspirin Seems to Improve Prognosis
Research suggests that premenopausal women who took two or more aspirin each week in the years after a diagnosis of early-stage breast cancer have a better prognosis than women who don't take aspirin.
-
Even Small HER2-Positive Cancers Have Higher Recurrence Risk
Small (1 cm or smaller), early-stage, HER2-positive breast cancers are more likely to come back (recur) and spread to parts of the body away from the breast (metastasize) than small, early-stage HER2-negative breast cancers, which suggests that treating these cancers with Herceptin (chemical name: trastuzumab) may make sense.
-
Lymph Node Ultrasound Before Surgery Can Help Find Cancer Spread
Ultrasound of underarm lymph nodes can determine if cancer has spread to those lymph nodes in some cases.
-
Isolated Cancer Cells in Lymph Nodes Need Treatment After Surgery
Women diagnosed with node-negative, early-stage breast cancer -- but with isolated cancer cells in the sentinel lymph node -- were 56% less likely to survive without the breast cancer coming back in the 5 years after treatment compared to women who were truly node negative (no cancer cells at all in the sentinel lymph node). This suggests that women diagnosed with isolated cancer cells in the sentinel node should be treated as if the cancer is node-positive.
-
Women Treated for Hormone-Receptor-Negative Cancers More Likely to be Diagnosed with New Cancer in Other Breast
Research shows that women treated for hormone-receptor-negative breast cancer are more than 3 times more likely to be diagnosed with a new cancer (either hormone-receptor-positive or -negative) in the other breast compared to women treated for hormone-receptor-positive breast cancer.
-
New Guidelines for Early-Stage Breast Cancer Recommend Treatment Based on Individual Cancer Characteristics
A large group of cancer experts created new guidelines for treating early-stage breast cancer; the guidelines recommend that chemotherapy, targeted therapies, radiation therapy, and hormonal therapy should be based on the characteristics of each individual cancer being treated.
-
Micrometastases in Lymph Nodes Need Treatment
When small groups of breast cancer cells are found in the sentinel lymph node during surgery to remove early-stage breast cancer, they need to be treated to reduce the risk of the cancer coming back.
-
New Tool Can Help Predict Recurrence Risk
A new tool that looks at four breast cancer characteristics seems to do a good job of predicting whether early-stage hormone-receptor-positive breast cancer is likely to come back (recurrence). The tool assessed recurrence in women diagnosed with early-stage hormone-receptor-positive breast cancer that had been treated with hormonal therapy before surgery.
11–20 of 31 articles
